Certain individuals should avoid or use caution with CJC 1295, especially those with: Hormone-sensitive cancer s (GH can promote cell growth, which may be risky for those with a history of cancer) Diabetes or insulin resistance (GH impacts blood sugar levels) Severe cardiovascular conditions (fluid retention can increase blood pressure) For anyone considering CJC 1295, its always best to consult a healthcare provider to weigh the benefits against potential risks
Without proper clinical studies and regulation, users face uncertainty regarding safety, efficacy, and long-term effects, making their unsupervised use a potentially risky endeavor
This is why we often recommend pairing our Liposomal Vitamin C with a high-quality Vitamin C source to maximize the antioxidant network in your body
CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027
Peptide supplements Collagen peptide powders (e.g., bovine, marine, multi-source): Hydrolyzed for improved absorption to support skin, joints, bones and hair